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S U M M A R Y
Objective: For reasons that have yet to be elucidated, the uptake of preventive measures against
infectious diseases by Hajj pilgrims is variable. The aim of this study was to identify the preventive
advice and interventions received by Australian pilgrims before Hajj, and the barriers to and facilitators
of their use during Hajj.
Methods: Two cross-sectional surveys of Australians pilgrims aged 18 years were undertaken, one
before and one after the Hajj 2014.
Results: Of 356 pilgrims who completed the survey (response rate 94%), 80% had the inﬂuenza vaccine,
30% the pneumococcal vaccine, and 30% the pertussis vaccine. Concern about contracting disease at Hajj
was the most cited reason for vaccination (73.4%), and not being aware of vaccine availability was the
main reason for non-receipt (56%). Those who obtained pre-travel advice were twice as likely to be
vaccinated as those who did not seek advice. Of 150 pilgrims surveyed upon return, 94% reported
practicing hand hygiene during Hajj, citing ease of use (67%) and belief in its effectiveness (62.4%) as the
main reasons for compliance; university education was a signiﬁcant predictor of hand hygiene
adherence. Fifty-three percent used facemasks, with breathing discomfort (76%) and a feeling of
suffocation (40%) being the main obstacles to compliance.
Conclusion: This study indicates that there are signiﬁcant opportunities to improve awareness among
Australian Hajj pilgrims about the importance of using preventive health measures.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The transmission of infectious diseases is high at mass
gatherings such as the annual Hajj pilgrimage in Makkah, Saudi
Arabia.1 Hajj is the largest annual mass gathering on the planet,
with around two to three million people attending from over
180 countries. Intense congestion, shared accommodation, air* Corresponding author. Tel.: +61 29845 1489.
E-mail address: amani.alqahtani@health.nsw.gov.au (A.S. Alqahtani).
http://dx.doi.org/10.1016/j.ijid.2016.02.005
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).pollution, and compromised hygiene all contribute to the
transmission of infections at Hajj, most notably acute respiratory
infections (ARIs).1,2
Hajj presents a public health challenge for Saudi Arabia, as the
authorities need to cater for an increasing number of pilgrims and
respond to emerging infections such as the Middle East respiratory
syndrome coronavirus (MERS-CoV).3,4 It is also challenging for the
countries sending pilgrims, since these pilgrims can import
epidemic diseases to their home countries upon return. In an
effort to reduce the risk of infectious diseases at Hajj, an array of
preventive measures have been recommended by the Saudiciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Health recommendations for travellers to Saudi Arabia for Hajj 20145
Health hazard Vaccine Countries required Other preventive measures
Air-borne diseases
Meningococcal disease Quadrivalent meningococcal
vaccine (ACYW135)
Compulsory for all pilgrims Not applicable
Inﬂuenza Seasonal inﬂuenza Recommended for all, in
particular at-risk pilgrims
Not applicable
MERS-CoV and other respiratory
infections
Not available Recommended for all People aged 65 years, those with chronic diseases,
pregnant women, and children aged <12 years
recommended to postpone Hajj 2014
Hand washing with water or disinfectant
Cough etiquette
Avoiding hand contact with eyes, nose, and mouth
Avoiding contact with ill persons
Facemask use
Maintenance of good personal hygiene and food hygiene
People at risk of severe diseases due to MERS-CoV
are asked to avoid close contact with animals when
visiting farms
Complying with hygiene measures while dealing
with animals
Avoiding contact with sick animals
Diphtheria Diphtheria Remaining up to date Not applicable
Pertussis Pertussis Remaining up to date Not applicable
Measles Measles Remaining up to date Not applicable
Mumps Mumps Remaining up to date Not applicable
Food- and water-borne diseases
Poliomyelitis OPV or IPV Compulsory for pilgrims from
endemic countries
Other pilgrims should
remain up to date
Not applicable
Soil-borne diseases
Tetanus Tetanus Remaining up to date Not applicable
Vector-borne diseases
Yellow fever Yellow fever Compulsory for pilgrims
from endemic countries
and those transiting through
endemic countries
Not applicable
Health education
Health authorities in countries of origin are required to provide health information to pilgrims on infectious disease symptoms, modes of transmission, and measures for
prevention
MERS-CoV, Middle East respiratory syndrome coronavirus; OPV, oral poliovirus vaccine; IPV, inactivated poliovirus vaccine.
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hygiene measures (Table 1).5 However, studies have demonstrated
that vaccine uptake and compliance with hygiene and protective
measures are highly variable among pilgrims,6,7 and the reasons
behind this variability remain unclear.
To date few studies have assessed the knowledge, attitudes, and
beliefs in relation to preventive measures among Hajj pilgrims. A
recent qualitative study of Australian pilgrims found that
considerable misconceptions about preventive measures and the
risk of respiratory infections prevail among Hajj pilgrims.8 A
French study demonstrated that less than half of pilgrims were
aware of social distancing and facemask use as precautions against
respiratory infections,9 but no study has explored the barriers to
and facilitators of the uptake of preventive measures. To address
these questions, two cross-sectional surveys were conducted
among Australian pilgrims, one before and one after the Hajj 2014,
to identify what preventive advice and interventions pilgrims
received before travel, and what factors inﬂuenced their compli-
ance with these measures while they were there.
2. Materials and methods
2.1. Study design
Two cross-sectional self-administered questionnaires were
distributed among Australian Hajj pilgrims aged 18 years in
2014. The ﬁrst survey was conducted on a group of departingpilgrims approximately 1 month before Hajj (pre-Hajj study). The
second survey was conducted on a second, separate group of
pilgrims immediately after their return to Australia (post-Hajj
study).
2.1.1. Pre-Hajj survey
The pre-Hajj survey collected data on socio-demographic
characteristics, Hajj itinerary details, and the receipt of pre-travel
advice, including vaccinations. The questionnaire also assessed the
pilgrims’ knowledge of and attitudes towards preventive mea-
sures, and their risk perception of diseases occurring at Hajj,
including inﬂuenza, pneumonia, and blood-borne diseases.
2.1.2. Post-Hajj survey
The post-Hajj questionnaire assessed the actual compliance
with infection control measures (such as the use of facemasks,
hand disinfectants, and handkerchiefs) during Hajj, and the
barriers to and facilitators of the use of those preventive measures
while at Hajj. The surveys were primarily in English, with Arabic
translations available for those who preferred to complete the
survey in Arabic.
2.2. Participant recruitment
Muslims residing in the Greater Sydney area, New South Wales
(NSW) were the target population for the study. NSW has the
largest Muslim population (50%) of any state in Australia with the
Table 2
Pre- and post-Hajj surveys: differences in participant demographic characteristics
Factors Pre-Hajj group
n (%)
Post-Hajj group
n (%)
p-Valuea
Age, years
Median (range) 39 (18–79) 41 (18–72) 0.50
Mean (SD) 40.6 ( 13.2) 40.6 ( 10.7)
Sex
Male 213 (60) 71 (47) 0.01*
Female 143 (40) 79 (53)
Country of birthb
Australia 102 (32) 34 (23) <0.01*
Lebanon 73 (23) 22 (15)
Indonesia 41 (13) 50 (35)
Pakistan 33 (11) 8 (5)
Bangladesh 24 (7) 6 (4)
Other 44 (14) 27 (18)
Not answeredc 39 (11) 3 (2)
Years in Australia
10 years 48 (22) 36 (31) 0.08
>10 years 167 (78) 80 (69)
Employed
Yes 230 (65) 98 (65) 0.87
No 126 (35) 52 (34)
Presence of comorbidities
Yes 76 (22) 24 (16) 0.16
No 280 (78) 126 (84)
Highest education levelb
None 31 (9) 5 (3) <0.01*
School certiﬁcate 55 (15) 12 (3)
High school certiﬁcate 66 (19) 24 (16)
Certiﬁcate/diploma 75 (21) 32 (21)
University degree 89 (25) 48 (32)
Higher university degree 40 (11) 29 (19)
Number of times attending Hajj
First time 291 (82) 118 (79) 0.42
>1 time 65 (18) 32 (21)
a Asterisks indicate a signiﬁcant difference.
b By Chi-square for trend.
c Excluded from the total number.
Table 3
Pre-Hajj study: uptake of recommended vaccinesa
Vaccine status (1 vaccine)
Yes 297 (84)
No 50 (14)
Not sure 9 (2)
Vaccine name
Seasonal inﬂuenza vaccine 283 (80)
Pneumococcal vaccine 107 (30)
Pertussis (whooping cough) vaccine 107 (30)
Hepatitis A vaccine 59 (17)
Hepatitis B vaccine 61 (17)
MMR (measles, mumps and rubella) vaccine 36 (10)
Typhoid vaccine 45 (13)
Polio vaccine 28 (8)
Reasons for vaccinationb
I don’t want to get sick 218 (73)
My Hajj tour group leader recommended getting the vaccine(s) 190 (64)
My doctor advised me to get the vaccine(s) 158 (53)
The vaccine is effective in protecting me against diseases 135 (45)
Reasons for not being vaccinatedb
I didn’t know about them 28 (56)
I don’t think I will get a disease at Hajj, I’m under ‘Allah’s protection 16 (32)
I don’t need them because I don’t have any chronic disease 15 (30)
I don’t worry about getting sick 13 (26)
a Results are presented as the number and percentage (%).
b Some pilgrims cited more than one reason.
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18 years and over who were planning to attend the Hajj 2014 were
eligible for recruitment.
Potential participants were approached through Hajj tour
operators. The list of accredited Hajj travel agents in Australia,
including their location/address, was obtained from the Saudi
Arabian Embassy in Canberra, Australia. The selection of partici-
pants was based on the number of Hajj visas allocated for a given
travel agent: travel agents with the highest quota of Hajj visas were
approached ﬁrst, and the travel agents who dealt with diverse
ethnic groups, including Arabs, Africans, Indians, and Malays, were
prioritized to ensure a diverse sample.
For the pre-Hajj survey, departing pilgrims were approached at
weekly pre-Hajj seminars run by travel agents between August
1 and mid-September 2014. All pilgrims attending the seminars
were invited to take part in the study.
For the post-Hajj survey, a second group of pilgrims (separate to
the ﬁrst) were approached in person at community gatherings and
events within weeks of returning home from Hajj (between mid-
October and the end of December 2014). The study was promoted
using a number of methods, including the distribution of brochures
at mosques and community centres and by word of mouth.
2.3. Sample size
A consecutive sampling plan was used to ensure a sample that
was representative of pilgrims residing in NSW. Assuming that at
least 70% of respondents will have a general knowledge of infection
control measures, and considering an error margin of 5% to be
acceptable for this anonymous survey, a sample of 323 was
considered to be sufﬁcient for this study; assuming a non-
completion rate of the survey of 15–20%, a total of 380 participants
were targeted. The sample size of this study represents approxi-
mately 10% of Australian pilgrims to Hajj 2014 (which is
approximately 3500). Previous works studying the uptake of
vaccinations among Australian Hajj pilgrims showed that a
convenience sample of 10% of the target population is sufﬁcient.
2.4. Data analysis
The data collected were entered into an Excel spreadsheet. The
statistical analysis was performed using IBM SPSS Statistics version
19.0 (IBM Corp., Armonk, NY, USA). Pearson correlation coefﬁcients
and Chi-square tests were used to assess variables and determine
associations and correlations. Univariate factors with p-values of
<0.25 were entered into multivariable regression analyses. Two-
tailed p-values of 0.05 were considered statistically signiﬁcant in
the multivariable models.
2.5. Ethics approval
This study was reviewed and approved by the Human Research
Ethics Committee (HREC) at The University of Sydney (Project No.
2014/599).
3. Results
3.1. Pre-Hajj study
3.1.1. Demographics
A total of 380 respondents agreed to participate in the study, of
whom 356 (94%) completed the survey questionnaires. Their
demographic details are presented in Table 2. Eighty-two percent
of pilgrims (291/356) were attending Hajj for the ﬁrst time, and the
median duration of their stay in Saudi Arabia was 27 (range 7–40)
days.3.1.2. Vaccine uptake and associated factors
All respondents reported receiving meningococcal vaccine; the
majority (83%, 297/356) also received one or more other
recommended vaccines (Table 3). Factors inﬂuencing vaccine
uptake are listed in Table 3. Being aged >40 years was signiﬁcantly
associated with the uptake of recommended vaccines (odds ratio
Table 4
Post-Hajj study: association between participants’ beliefs about the effectiveness of
preventive measures and compliance with preventive measures
Pilgrims’ perception of
effectiveness
Compliance
n (%)
Non-compliance
n (%)
p-Valuea
Facemask
Very effective 39 (75) 14 (27) <0.01*
A little to somewhat effective 37 (48) 40 (52)
Not effective at all 4 (19) 16 (76)
Hand washing with water only
Very effective 64 (60) 43 (40) 0.02*
A little to somewhat effective 18 (46) 21 (54)
Not effective at all 0 4 (100)
Use of soap-based hand disinfectant
Very effective 70 (80) 17 (20) 0.02*
A little to somewhat effective 37 (70) 16 (30)
Not effective at all 3 (30) 7 (70)
Alcoholic hand disinfectant
Very effective 23 (41) 33 (59) 0.06
A little to somewhat effective 17 (28) 44 (72)
Not effective at all 6 (18) 27 (82)
Avoiding contact with ill people
Very effective 19 (26) 54 (74) 0.18
A little to somewhat effective 16 (24) 51 (76)
Not effective at all 0 10 (100)
a By Chi-square for trend; asterisks indicate a signiﬁcant difference.
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having a university education (OR 3.4, 95% CI 1.7–6.7, p = 0.01).
3.1.3. Pre-travel advice seeking and associated factors
Approximately two thirds (236/356) obtained ‘professional
travel health advice’ from one or more sources before Hajj,
including 57% (182/236) from general practitioners (GPs), 24% (55/
236) from a specialist travel clinic, 12% (27/236) from a speciﬁc
Hajj website (e.g., MoH website11), and 11% (25/236) from the
‘Smartraveller’ website.12 Of those who received professional pre-
travel advice, 81% (191/236) reported a positive experience with
the advice, while the rest described a negative experience.
One third (120/356) did not seek any ‘professional travel health
advice’ before Hajj. Reasons for not seeking pre-travel advice
included not recognizing the need to seek such advice (47%, 56/
120), preference for other sources, i.e., friends, family members,
and travel agents (32%, 39/120), reliance on previous experience/
knowledge (14%, 17/120), and previous negative experience of
seeking pre-travel advice (7%, 8/120). Being within the age band of
34 to 49 years was the only factor associated with receiving
professional pre-travel advice (OR 2.5, 95% CI 1.5–4, p = 0.01).
Additional pre-travel health advice sources were also reported,
including Hajj travel leaders (66%, 235/356), family members and
friends who had previous experience of performing Hajj (45%, 161/
356), and ‘general websites’ on the Internet (17%, 59/356). Forty-
six percent (164/356) were aware of the annual Hajj health
recommendations issued by the Saudi MoH.
Additionally, pilgrims who sought pre-travel advice from GPs
(OR 1.9, 95% CI 1–3.5, p = 0.03) or tour group leaders (OR 2.1, 95% CI
1.1–3.8, p = 0.01) before travelling to Hajj were twice as likely to be
vaccinated as those who did not.
3.1.4. Risk perception of diseases
Pilgrims were reportedly concerned about food poisoning (61%,
217/356), diarrhoea (59%, 210/356), inﬂuenza (58%, 206/356),
blood-borne diseases (49%, 173/356), skin diseases (45%, 160/356),
and pneumonia (33%, 117/356). However, there was no association
between the level of concern about inﬂuenza, pneumonia, and
blood-borne diseases and the uptake of the inﬂuenza, pneumo-
coccal, and hepatitis B vaccines, respectively (all p-values >0.2).
3.2. Post-Hajj study
3.2.1. Demographics
A total of 150 returned pilgrims were surveyed. Their
demographic characteristics are presented in Table 2. A large
proportion of pilgrims (79%, 118/150) had performed Hajj for the
ﬁrst time. They had stayed for a median duration of 25 (range
7–35) days.
3.2.2. Participants’ perceptions of the effectiveness of preventive
measures
The majority of participants, 71% (107/150), believed hand
washing (with water only) to be the most effective measure to
protect oneself from respiratory infections, while the uses of
alcoholic hand rubs (37%, 56/150) and facemasks (35%, 52/150)
were considered to be less effective. Only beliefs about the
effectiveness of facemasks and hand washing with water and soap
were signiﬁcantly associated with their actual use (p < 0.01)
(Table 4).
3.2.3. Compliance with preventive measures and associated factors
Half of the pilgrims (53%, 80/150) used facemasks to protect
themselves from infectious diseases during Hajj at least three
times a day. Participants described three major reasons for
facemask use: protection from disease (76%, 61/80), protectionfrom air pollution (58%, 46/80), and belief that facemasks are
effective in preventing ARIs (41%, 33/80). Less than half (47%, 70/
150) did not use a facemask. The reasons for non-compliance were
breathing discomfort (76%, 53/70), feeling of suffocation (40%, 28/
70), and thinking it was not necessary (31%, 22/70). In addition,
none of the demographic characteristics were associated with
facemask compliance (all p-values >0.25) and therefore these were
not entered into multivariable regression analyses.
A subgroup of women (n = 76) answered questions on their use
of the niqab (traditional face veil); of those who responded, 49%
(37/76) used only facemasks, 34% (26/76) used only the niqab, and
20% (15/76) used both a facemask and the niqab. Of those who used
the niqab (either alone or with a facemask), 51% (21/41) reported
that they did so because it is ‘airy’ and easier to breathe and 39%
(16/41) felt that it was comfortable to use.
3.2.4. Hand hygiene
Almost all (94%, 141/150) practised some kind of hand hygiene
during Hajj. This included hand washing with soap (73%, 110/150),
hand washing with water only (55%, 82/150), and alcoholic hand
disinfectant (31%, 46/150). Reasons inﬂuencing the pilgrims’
decision to use these methods included belief in the effectiveness
of hand hygiene in preventing infectious diseases (67%, 94/141)
and convenience and ease of use (62.4%, 88/141). Additionally,
those with a university education were more likely to use hand
hygiene measures than those without (OR 7.9, 95% CI 1.4–42.9,
p = 0.01).
3.2.5. Other measures
Respondents reported using other preventive measures includ-
ing disposable handkerchiefs (53%, 79/150), avoiding dense
crowding (29%, 43/150), avoiding contact with symptomatic
people (39%, 58/150), and practicing hand washing after touching
the ill (30%, 45/150).
4. Discussion
This appears to be the ﬁrst in-depth quantitative study
comparing the health knowledge attitudes, beliefs, and practices
of departing and returning Hajj pilgrims regarding preventive
measures against infectious diseases. This study found that
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the main facilitator of compliance with preventive measures. Not
recognizing the need to receive pre-travel advice was identiﬁed as
an important barrier. This survey found the inﬂuenza vaccine
coverage rate among Australian Hajj pilgrims in 2014 to be high
(80%). This is consistent with ﬁgures reported since 2012,13,14 and
much higher compared to recent data from some other countries
such as Turkey where the vaccination rate was only 7.1% during the
Hajj 2015,14 and France where the vaccination rate for 2014 was
zero due to vaccine non-availability,15 and compares well with the
overall vaccination rates among international pilgrims over recent
decades, which range between 0.7% and 100%.6,16
Inﬂuenza vaccine aside, the uptake of other recommended
vaccines was low. For instance, the uptake of pneumococcal
vaccine was only 30%. Previous Australian and international
surveys have reported coverage rates ranging from 2.5% to 36%.6,17
This is concerning because pneumonia is the leading cause of
hospital admission and an important cause of mortality at Hajj.18–20
Furthermore, surveys have shown that many pilgrims were not
aware that pneumonia is transmissible21 and preventable by
vaccination.22 There is currently no formal guidance from the Saudi
MoH on the use of pneumococcal vaccine for Hajj pilgrims, which
may partly explain this apparent lack of awareness (Table 1).23
The uptake of pertussis vaccine was 30%, compared with 10.6%
among French Hajj pilgrims in 2005.24 Additionally, the coverage
for hepatitis A and B vaccines were each 17%, which is higher than
the 11.5% uptake for hepatitis A reported among French pilgrims in
2005,24 and the 6% each for hepatitis A and B among Saudi pilgrims
in 2010.25 While a large proportion of Hajj pilgrims are from
countries with intermediate to high hepatitis B virus (HBV)
prevalence, the risk of contracting HBV at Hajj is not well
studied.26,27 It is known that a signiﬁcant proportion of pilgrims
engage in high-risk behaviours; for example it was found that
about 43% of male pilgrims shaved their heads with reused
razors,28 or had their heads shaved by non-professional (unli-
censed) barbers.25 Other studies have also reported high-risk
behaviours that increase the risk of hepatitis A, including buying
and eating food from street vendors.29 Despite this, hepatitis A and
B vaccines are not listed in the Saudi MoH recommendations for
Hajj pilgrims (Table 1).23
In this study, polio vaccine uptake was 8%, which is low
compared with the uptake among French pilgrims in 2006 (15%),30
and the uptake among pilgrims from other non-endemic countries
in 2013 (43%).31 Typhoid vaccine coverage was 13% in this study,
which compares well with the uptake rate of 9% among
international pilgrims in 2002.32 The present study appears to
report MMR (measles, mumps, and rubella) vaccine uptake (10%)
for the ﬁrst time.
The participants cited several reasons for not receiving the
recommended vaccines, the most common being that they were
unaware that the vaccines were recommended. These results are
consistent with the ﬁndings of Memish et al., who reported a lack
of knowledge to be a signiﬁcant factor for poor uptake of the
seasonal inﬂuenza vaccine among pilgrims.33 Conversely, previous
Australian studies have reported reliance on natural immunity as
the main reason for not being vaccinated against inﬂuenza in 2011,
while low risk perception of contracting inﬂuenza was the main
reason in 2012.13
A unique ﬁnding of this study is that pilgrims who received pre-
travel advice from GPs and Hajj tour group leaders were twice as
likely to be vaccinated as those who did not receive such advice.
Barasheed et al. found that receiving advice from Hajj group
leaders was the main motivator for the uptake of inﬂuenza vaccine
among Australian Hajj pilgrims in 2012.13
This survey also revealed that older pilgrims (aged >40 years)
were more likely to take up the recommended vaccines. Similarly,Gautret et al. demonstrated that inﬂuenza vaccine coverage
increased with age in French pilgrims.24 This could be due to
the fact that older people are more aware of their health, or it could
be due to an increasing number of pre-existing illnesses as people
age. Another study among French pilgrims found that ‘at risk’
pilgrims were signiﬁcantly more likely to be advised to receive
pneumococcal vaccine than those who were not ‘at risk’.22 This
may explain why vaccine uptake has been found to increase with
age in some studies.24,34
Although respiratory infections are the most common diseases
during Hajj,1 the participants in this study were more concerned
about food-borne illness than ARIs. Limited knowledge and
perception of diseases among pilgrims has been found in other
studies; an Australian study found that 42% of pilgrims in
2014 were not aware that pneumonia can be transmissible.21
Similarly, French pilgrims in 2014 did not perceive pneumonia as a
severe condition, and were not aware of the existence of a vaccine
against it.22
No association was found between the disease risk perception
for inﬂuenza, pneumonia, and hepatitis B and the uptake of the
respective vaccines. This contradicts other data, which demon-
strated that an increased risk perception of pandemic inﬂuenza A
(H1N1) was signiﬁcantly associated with inﬂuenza vaccine uptake
among US pilgrims in 2009.35
Almost all of the participants in the present study used some
kind of hand hygiene; this was higher compared with French
pilgrims in 2013 (50%).36 More than half of the pilgrims used
facemasks in this study, similar to French pilgrims in 2013.36
Nevertheless, previous studies have reported that only half of the
participants were aware of the availability of non-pharmaceutical
preventive measures against respiratory infections.9,33
Belief that hand hygiene is easy to use and effective in
preventing infections were the main reasons for uptake among the
present sample. Conversely, facemasks were less accepted. Among
non-users, discomfort and difﬁculty in breathing were barriers to
their use. Those who used facemasks believed that they were
effective in preventing infectious diseases. Similar quantitative
ﬁndings have been reported among members of the general
Singaporean community,37 but not previously among Hajj
pilgrims. Another important factor identiﬁed as a driver for the
use of facemasks was protection from air pollution. A recent study
found that the air pollution level in Makkah during the Hajj
consistently exceeds internationally acceptable standards,38 and
therefore this perception is probably justiﬁed and could inform
health promotion policy.
Thirty-four percent of female pilgrims in the present sample
preferred to use a traditional face cover (niqab) to a facemask
during Hajj. In contrast, other studies found that higher propor-
tions (over 70%) of Saudi women preferred the niqab over
facemasks at Hajj 2002 and 2003.39,40 In the exploration of why
some women prefer using the niqab, it was found that comfort and
breathability were contributing factors.
In this study, two thirds of pilgrims sought pre-travel advice
from health professionals; this is similar to the results of a survey
that found that 65% of Arab pilgrims received health advice before
departing to Hajj.41 GPs were the most cited sources, followed by
specialist travel clinics. This result is supported by a study that
found GPs to be the most trusted sources of health advice among
Australian pilgrims in 2014.21 Interestingly, only 12% of the present
sample sought advice from the Saudi MoH website. This is different
to the ﬁndings of a study that showed the Saudi MoH to be the
main source of health information among pilgrims from Arab
countries (69%).41 This difference may be due to language barriers.
Not recognizing the need to seek pre-travel health advice and
the preference for other information sources (i.e., friends, family
members, and travel agents) were the main barriers to seeking
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a recent Australian study, which also demonstrated a high level of
conﬁdence in advice from non-health professional sources such as
family, friends, and travel agents.8 The present study identiﬁed
that being aged between 34 and 49 years was the only factor
signiﬁcantly associated with seeking pre-travel health advice.
Therefore, enhancing awareness among other groups of Hajj
pilgrims, especially elderly adults and those with pre-existing
illnesses, about the importance of seeking professional pre-travel
advice could be an important strategy to improve the uptake of
preventive measures. Moreover, providing GPs with culturally
appropriate health information on Hajj and the preventive
measures recommended by the Saudi MoH could also facilitate
uptake.42
This study has some limitations. Two different groups were
surveyed and the groups showed signiﬁcant differences in
demographic characteristics, particularly in sex, education level,
and country of birth. Also, the sample size of the post-Hajj group
was smaller than intended. These could limit the generalizability
of the ﬁndings of one group to the other. These limitations are
being addressed by a second, larger cohort study among
Australian pilgrims during Hajj 2015, and a qualitative study
among GPs and tour group leaders is underway. Despite these
limitations this study has uniquely identiﬁed the barriers to and
facilitators of the uptake of preventive measures among Austra-
lian Hajj pilgrims, providing important preliminary data upon
which to build.
This study shows that there are signiﬁcant opportunities to
improve awareness among Hajj pilgrims about the importance of
using preventive health measures and indicates the need for better
communication of ofﬁcial health information from the Saudi MoH
to a broader international audience.
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